Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1999
08/10/1999US5935995 Poly-, oligo- and monosaccharides of drugs, e.g. nitrogen mustard gas, quinine and dipyridamole; stability; slow release; antiarthitic agents; enzyme inhibitors
08/10/1999US5935975 Agonist-antagonist combination to reduce the use of nicotine and other drugs
08/10/1999US5935967 Pharmaceutical formulations of highly lipophilic camptothecin derivatives
08/10/1999US5935939 A solid state amorphous excipient for gastric antisecretory agent, antiulcer agent
08/10/1999US5935936 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
08/10/1999US5935610 Antacid comprising magnesium oxide, calcium carbonate and avitamine, mineral supplement for reducing stomach acidity while at the same time providing a nutritional supplement
08/10/1999US5935604 A pulse effect, followed by controlled release and absorption of nicotine to provide a sustained high level of absorbed nicotine
08/10/1999US5935603 Pulverulent water soluble composition of: a salt of a strong base in excess, a nonsalified active ingredient normally only water soluble at alkaline ph, and a buffer that holds the ph at a precise range during and after dissolution; stability
08/10/1999US5935602 Dosage forms of risedronate
08/10/1999US5935601 Acylated peptide as a carrier for oral administration
08/10/1999US5935596 Delivery of skin benefit agents via adhesive strips
08/10/1999US5935593 Chemo-mechanical expansion delivery system
08/10/1999US5935592 Method for treating vaginitis and endometriosis
08/10/1999US5935566 Stable aqueous alfa interferon solution formulations
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999US5935559 Silicone composition containing a water-sensitive active agent
08/10/1999US5935553 Methods of preparing gas-filled liposomes
08/10/1999CA2201264C Immediate release ph-independent solid dosage form of cisapride
08/10/1999CA2131647C Sustained release heterodisperse hydrogel systems for insoluble drugs
08/10/1999CA2010981C Stabilized fat-soluble vitamin compositions
08/09/1999WO1999039680A1 Antifungal nail lacquer and method using same
08/05/1999WO1999038869A1 Therapeutic compounds
08/05/1999WO1999038821A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
08/05/1999WO1999038536A1 Absorbable microparticles
08/05/1999WO1999038535A1 Process for making absorbable microparticles
08/05/1999WO1999038528A2 Vaccine formulations
08/05/1999WO1999038527A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
08/05/1999WO1999038511A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
08/05/1999WO1999038506A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
08/05/1999WO1999038495A2 Controlled release delivery of peptide or protein
08/05/1999WO1999038493A1 Microparticle inhalation formulations
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999038472A2 Topical vasodilatory gel composition and methods of use and production
08/05/1999WO1999038467A1 Treatment of female sexual dysfunction
08/05/1999WO1999038390A1 Sweetening agent
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999024472A3 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999018959A9 Pharmaceutical formulation comprising glycine as a stabilizer
08/05/1999WO1999017740A9 Peptide/lipid complex formation by co-lyophilization
08/05/1999WO1999015542A3 Linker nucleoside, and production and use of the same
08/05/1999WO1998036778A8 Sustained drug delivery and compositions useful therefor
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2322289A1 Treatment of female sexual dysfunction
08/05/1999CA2319711A1 Vaccine
08/05/1999CA2319627A1 Therapeutic compounds
08/05/1999CA2319514A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
08/05/1999CA2319202A1 Preparation for treatment of erectile dysfunction
08/05/1999CA2319059A1 Sweetening agent
08/05/1999CA2318513A1 Process for making absorbable microparticles
08/05/1999CA2318152A1 Absorbable microparticles
08/04/1999EP0933084A1 Aqueous composition containing cromoglycic acid
08/04/1999EP0933081A1 Pharmaceutical compositions containing mupirocin
08/04/1999EP0933079A1 Free-flowable, directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
08/04/1999EP0932653A1 Collagen or gelatin crumble composition and uses
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932614A1 Peptide prodrugs containing an alpha-hydroxyacid linker
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
08/04/1999EP0932404A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
08/04/1999EP0932399A1 Water soluble paclitaxel prodrugs
08/04/1999EP0932397A2 Medicinal aerosol formulations comprising budesonide
08/04/1999EP0932396A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
08/04/1999EP0932391A2 Fusogenic liposome composition and method
08/04/1999EP0932390A1 Therapeutic liposome composition and method
08/04/1999EP0932389A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum
08/04/1999EP0932388A2 Dosage form and method for administering drug
08/04/1999EP0789558B1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery
08/04/1999EP0585242B1 Wound healing
08/04/1999CN1225018A Inclusion complex containing indole selective serotonin agonist
08/04/1999CN1225017A Quickly disintegrable compression-molded materials and process for producing the same
08/04/1999CN1225007A Cationic virosomes as transfer system for genetic material
08/04/1999CN1224623A Compounding method of bone morphogenesis protein to calcined bone
08/04/1999CN1224615A Salvia plebeia extract and its use
08/04/1999CN1224610A Ibuprofen compositions
08/04/1999CA2256942A1 Human growth hormone-containing aqueous pharmaceutical composition
08/03/1999US5932707 Thioether-containing metal chelating compounds
08/03/1999US5932602 Treatment of platelet derived growth factor related disorders such as cancers
08/03/1999US5932597 Anaesthetic formulation
08/03/1999US5932562 Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932547 Non-aqueous polar aprotic peptide formulations
08/03/1999US5932462 Pure water soluble polymer linked to single ionizable reactive group by nonreactive linkage fragments with no aromatic rings and ester groups; can be purified by ion exchange chromatography
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present
08/03/1999US5932249 Budesonide pellets with a controlled released pattern and process for producing the same
08/03/1999US5932248 Ionic polymer matrix
08/03/1999US5932247 Microcrystalline cellulose, lactose and pregelatinized starch; gelatin; croscarmellose sodium
08/03/1999US5932243 Galenical formulations
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
08/03/1999US5932235 Jellied medicinal composition for oral administration
08/03/1999US5932232 Product for topical application containing a lipase and an active ingredient precursor
08/03/1999US5932227 Percutaneously administrable base composition and drug composition prepared therefrom
08/03/1999US5932188 Therapeutic and diagnostic imaging compositions and methods
08/03/1999CA1340694C Biodegradable in-situ forming implants and methods of producing the same
07/1999
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037779A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same
07/29/1999WO1999037753A1 Enzyme catalyzed therapeutic agents
07/29/1999WO1999037337A2 Prostheses with associated growth factors
07/29/1999WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use
1 ... 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 ... 1712